Benazepril Hydrochloride
- Product NDC
- 70934-983
- 11-digit product format
- 709340983
- Labeler code
- 70934
- Product ID
- 70934-983_f06feef0-1e62-feb6-e053-2a95a90a9c05
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Benazepril Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA078212
- Marketing category
- ANDA
- Marketing start
- 2022-06-28
- Marketing end
- 2023-12-31
- Substance
- BENAZEPRIL HYDROCHLORIDE
- Active strength
- 40 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| N1SN99T69T | BENAZEPRIL HYDROCHLORIDE | 86541-74-4 | BENAZEPRIL HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-983-30 | 70934098330 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70934-983-30) | 2022-06-28 | 0000-00-00 | No | No | Current |